Beyond the genome and proteome: Targeting protein modifications in cancer

Current Opinion in Pharmacology

Volumn 12, Issue 4, 2012, Pages 408-413

  Markiv, Anatoliy ^a   Rambaruth, Neela Devi Sing ^a   Dwek, Miriam Victoria ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER; BORTEZOMIB; MEMBRANE RECEPTOR; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PALMITIC ACID; PROTEOME;

ENZYME GLYCOSYLATION; ENZYME PHOSPHORYLATION; GENOME; HUMAN; HYDROXYLATION; MALIGNANT NEOPLASTIC DISEASE; NITRATION; OXIDATIVE STRESS; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN DEGRADATION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SULFATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

GENOME; GLYCOSYLATION; HUMANS; NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME;

EID: 84864969137     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.04.003     Document Type: Review

References (47)

1. G.W. Hart, and R.J. Copeland Glycomics hits the big time Cell 143 2010 672 676
2. H. Schachter, and H.H. Freeze Glycosylation diseases: quo vadis? Biochim Biophys Acta 1792 2009 925 930
3. Y. Song, J.A. Aglipay, J.D. Bernstein, S. Goswami, and P. Stanley The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression Cancer Res 70 2010 3361 3371
4. R. Apweiler, H. Hermjakob, and N. Sharon On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database Biochim Biophys Acta 1473 1999 4 8
5. H. Lis, and N. Sharon Protein glycosylation. Structural and functional aspects Eur J Biochem 218 1993 1 27
6. M.T. Walsh, H. Watzlawick, F.W. Putnam, K. Schmid, and R. Brossmer Effect of the carbohydrate moiety on the secondary structure of beta 2-glycoprotein. I. Implications for the biosynthesis and folding of glycoproteins Biochemistry 29 1990 6250 6257
7. L.A. Lasky Selectins: interpreters of cell-specific carbohydrate information during inflammation Science 258 1992 964 969
8. S.W. Homans, R.A. Dwek, and T.W. Rademacher Solution conformations of N-linked oligosaccharides Biochemistry 26 1987 6571 6578
9. R.S. Haltiwanger, and P. Stanley Modulation of receptor signaling by glycosylation: fringe is an O-fucose-beta1,3-N-acetylglucosaminyltransferase Biochim Biophys Acta 1573 2002 328 335
10. I. Brockhausen Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions EMBO Rep 7 2006 599 604
11. B. Adamczyk, T. Tharmalingam, and P.M. Rudd Glycans as cancer biomarkers Biochim Biophys Acta 1820 2012 1347 1353 10.1016/j.bbagen.2011.12.001
12. H. Korekane, T. Hasegawa, A. Matsumoto, N. Kinoshita, E. Miyoshi, and N. Taniguchi Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein Biochim Biophys Acta 1820 2012 1405 1411 10.1016/j.bbagen.2011.12.015
13. N.D. Rambaruth, and M.V. Dwek Cell surface glycan-lectin interactions in tumor metastasis Acta Histochem 113 2011 591 600
14. J.W. Dennis, M. Granovsky, and C.E. Warren Glycoprotein glycosylation and cancer progression Biochim Biophys Acta 1473 1999 21 34
15. J.N. Contessa, M.S. Bhojani, H.H. Freeze, B.D. Ross, A. Rehemtulla, and T.S. Lawrence Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy Clin Cancer Res 16 2010 3205 3214
16. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA: Control of mucin-type O-glycosylation - a classification of the polypeptide GalNAc-transferase gene family. Glycobiology [Epub ahead of print].
17. J.M. Burchell, A. Mungul, and J. Taylor-Papadimitriou O-linked glycosylation in the mammary gland: changes that occur during malignancy J Mammary Gland Biol Neoplasia 6 2011 355 364
18. S.A. Brooks The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression Histol Histopathol 15 2000 143 158
19. O. Blixt, D. Bueti, B. Burford, D. Allen, S. Julien, M. Hollingsworth, A. Gammerman, I. Fentiman, J. Taylor-Papadimitriou, and J.M. Burchell Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis Breast Cancer Res 13 2011 R25
20. D.W. Kufe Mucins in cancer: function, prognosis and therapy Nat Rev Cancer 9 2009 874 885
21. C. Slawson, T. Lakshmanan, S. Knapp, and G.W. Hart A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin Mol Biol Cell 19 2008 4130 4140
22. R.J. Copeland, J.W. Bullen, and G.W. Hart Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab 295 2008 E17 E28
23. B. Laczy, B.G. Hill, K. Wang, A.J. Paterson, C.R. White, D. Xing, Y.F. Chen, V. Darley-Usmar, S. Oparil, and J.C. Chatham Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system Am J Physiol Heart Circ Physiol 296 2009 H13 H28
24. B.D. Lazarus, D.C. Love, and J.A. Hanover O-GlcNAc cycling: implications for neurodegenerative disorders Int J Biochem Cell Biol 41 2009 2134 2146
25. C. Slawson, and G.W. Hart O-GlcNAc signalling: implications for cancer cell biology Nat Rev Cancer 11 2011 678 684
26. N.D.S. Rambaruth, P. Greenwell, and M.V. Dwek The lectin Helix pomatia agglutinin recognises O-GlcNAc containing glycoproteins in human breast cancer Glycobiology 22 2012 839 848
27. M.B. Lazarus, Y. Nam, J. Jiang, P. Sliz, and S. Walker Structure of human O-GlcNAc transferase and its complex with a peptide substrate Nature 469 2011 564 567
28. H. Heindl, P. Greenwell, N. Weingarten, T. Kiss, G. Terstyanszky, and R.O. Weinzierl Cation-pi interactions induce kinking of a molecular hinge in the RNA polymerase bridge-helix domain Biochem Soc Trans 39 2011 31 35
29. R.S. Haltiwanger, K. Grove, and G.A. Philipsberg Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy- d-glucopyranosylidene)amino-N-phenylcarbamate J Biol Chem 273 1998 3611 3617
30. H.C. Dorfmueller, V.S. Borodkin, D.E. Blair, S. Pathak, I. Navratilova, and D.M. Van Aalten Substrate and product analogues as human O-GlcNAc transferase inhibitors Amino Acids 40 2011 781 792
31. A.J. Levine, and A.M. Puzio-Kuter The control of the metabolic switch in cancer by oncogenes and tumor suppressor genes Science 330 2010 1340 1344
32. S.G. Julien, N. Dube, S. Hardy, and M.L. Tremblay Inside the human cancer tyrosine phosphatome Nat Rev Cancer 11 2011 35 49
33. T.A.J. Haystead, A.T.R. Sim, D. Carling, C. Honnor, Y. Tsukitani, P. Cohen, and D.G. Hardie Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism Nature 337 1989 78 81
34. E.A. Slee, B. Benassi, R. Goldin, S. Zhong, I.B. Ratnayaka, G. Landino, and X. Lu Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo Proc Natl Acad Sci USA 107 2010 1979 19484
35. M. Arif, P. Senapati, J. Shandilya, and T.K. Kundu Protein lysine acetylation in cellular function and its role in cancer manifestation Biochim Biophys Acta 1799 2011 702 716
36. J.M. Wagner, B. Hacknson, M. Lubbert, and M. Jung Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy Clin Epigenet 1 2010 117 136
37. E.M. Duncan, and C.D. Allis Errors in erasure: links between histone lysine methylation removal and disease Prog Drug Res 67 2011 69 90
38. A. Abdollahi, and J. Folkman Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy Drug Resist Updat 13 2010 16 28
39. H. Ischiropoulos Protein tyrosine nitration - an update Arch Biochem Biophys 484 2009 117 121
40. G.O. Osoata, S. Yamamura, M. Ito, C. Vuppusetty, I.M. Adcock, P.J. Barnes, and K. Ito Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2 Biochem Biophys Res Commun 384 2010 366 371
41. J. Myllyhrju HIF prolyl 4-hydroxylases and their potential as drug targets Curr Pharm Des 15 2009 3878 3885
42. C. Slaun, J. Greaves, and L.H. Chamberlain The intracellular dynamic of protein palmitoylation J Cell Biol 191 2010 1229 1238
43. B. Cuiffo, and R. Ren Palmitoylation of oncogenic NRAS is essential for leukemogenesis Blood 115 2010 3598 3605
44. E.T.H. Yeh, L. Gong, and T. Kamitani Ubiquitin-like proteins: new wines in new bottle Gene 248 2000 1 14
45. I. Bosanac, I.E. WQertz, B. Pan, C. Yu, S. Kusum, C. Lam, L. Phu, Q. Phung, B. Maurer, and D. Arnott Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling Mol Cell 40 2010 548 557
46. A.J. Jakubowiak, D.M. Benson, W. Bensinger, D.S. Siegel, T.M. Zimmerman, A. Mohrbacher, P.G. Richardson, D.E. Afar, A.K. Singhal, and K.C. Anderson Phase I trial of anti-CS1 monoclonal antibody Elotuzumab in combination with Bortezomib in the treatment of relapsed/refractory multiple myeloma J Clin Oncol 2012 [Epub ahead of print]
47. L. Bedford, J. Lowe, L.R. Dick, R.J. Mayer, and J.E. Brownell Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets Nat Rev Drug Discov 10 2011 29 46